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Introduction
The upstroke of optical action potentials (APs) recorded from intact hearts are generally recognised to be slower than those
recorded with microelectrodes. This is thought to reflect spatial signal averaging within the volume of tissue that makes up the
optical signal. However, to date, there has been no direct experimental study on the relationship between CV and optical AP
upstroke morphology in the intact heart. Notably, it is known that sodium channel block and gap junction inhibition, which both
slow CV, exert differential effects on the upstroke velocity of microelectrode-recorded APs. Whether such differences are evident
in optical APs is not known. The present study sought to determine the relationship between tissue CV and optical AP upstroke
velocity in intact mouse hearts.
Materials and methods
Isolated, perfused mouse hearts were stained with the potentiometric dye Rh-237. Fluorescent signals were recorded from across
the anterior surface of the left and right ventricles during constant pacing. Maximum rate of change in fluorescence (dF/dtmax)
and tissue CV were assessed in control conditions, during an acute period of low-flow ischaemia, and following perfusion of
flecainide (1‐3 mol/L), a sodium channel blocker, or carbenoxolone (10‐50 mol/L), a gap junction inhibitor.
Results
During epicardial pacing, an anisotropic pattern was observed in both activation and dF/dtmax maps, with more rapid optical AP
upstroke velocities orientated along the fastest conduction paths (and vice versa). Low-flow ischaemia resulted in a
time-dependent slowing of ventricular CV, which was accompanied by a concomitant reduction in optical AP upstroke velocity. All
values returned to baseline on tissue reperfusion. Both flecainide and carbenoxolone were associated with a concentration-
dependent reduction in CV and decrease in optical AP upstroke velocity, despite distinct mechanisms of action. Similar responses to
carbenoxolone were observed for low‐ (156 m pixel with) and high‐ (20 m pixel width) magnification recordings. Comparison
of data from all interventions revealed a linear relationship between CV and upstroke dF/dt.
Conclusion
In intact mouse hearts, slowing of optical AP upstroke velocity is directly proportional to the change in CV associated with low-flow
ischaemia, sodium channel block and gap junction inhibition.
  
 Contribution to the field
Optical mapping is a commonly used imaging modality used for the measurement of cardiac electrophysiological parameters. In this
study, we have examined how changes in electrical conduction velocity in the heart impact on the morphology of optically recorded
action potentials (specifically the optical action potential upstroke). To our knowledge, this is the first time this relationship has
been examined experimentally and in a systematic manner. We compare the effects of a variety of interventions that slow CV, but
through different mechanisms of action. Our results indicate that the relationship between CV and the upstroke of optically-
recorded action potentials differs from classical observations made using microelectrode recording techniques, whilst confirming
previous theoretical predictions (i.e. the results of computational modelling studies). Our results provide important information on
the properties of optical derived action potentials and their relationship with changes in underlying cellular and tissue cardiac
electrophysiology.
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Abstract (339 words) 39 
Introduction 40 
The upstroke of optical action potentials (APs) recorded from intact hearts are generally 41 
recognised to be slower than those recorded with microelectrodes. This is thought to reflect 42 
spatial signal averaging within the volume of tissue that makes up the optical signal. However, 43 
to date, there has been no direct experimental study on the relationship between CV and optical 44 
AP upstroke morphology in the intact heart. Notably, it is known that sodium channel block 45 
and gap junction inhibition, which both slow CV, exert differential effects on the upstroke 46 
velocity of microelectrode-recorded APs. Whether such differences are evident in optical APs 47 
is not known. The present study sought to determine the relationship between tissue CV and 48 
optical AP upstroke velocity in intact mouse hearts. 49 
 50 
Materials and methods 51 
Isolated, perfused mouse hearts were stained with the potentiometric dye Rh-237. Fluorescent 52 
signals were recorded from across the anterior surface of the left and right ventricles during 53 
constant pacing. Maximum rate of change in fluorescence (dF/dtmax) and tissue CV were 54 
assessed in control conditions, during an acute period of low-flow ischaemia, and following 55 
perfusion of flecainide (1-3mol/L), a sodium channel blocker, or carbenoxolone (10-56 
50mol/L), a gap junction inhibitor.  57 
 58 
Results 59 
During epicardial pacing, an anisotropic pattern was observed in both activation and dF/dtmax 60 
maps, with more rapid optical AP upstroke velocities orientated along the fastest conduction 61 
paths (and vice versa). Low-flow ischaemia resulted in a time-dependent slowing of ventricular 62 
CV, which was accompanied by a concomitant reduction in optical AP upstroke velocity. All 63 
values returned to baseline on tissue reperfusion. Both flecainide and carbenoxolone were 64 
associated with a concentration-dependent reduction in CV and decrease in optical AP upstroke 65 
velocity, despite distinct mechanisms of action. Similar responses to carbenoxolone were 66 
observed for low- (156m pixel with) and high- (20m pixel width) magnification recordings. 67 
Comparison of data from all interventions revealed a linear relationship between CV and 68 
upstroke dF/dt. 69 
 70 
 71 
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 72 
Conclusion 73 
In intact mouse hearts, slowing of optical AP upstroke velocity is directly proportional to the 74 
change in CV associated with low-flow ischaemia, sodium channel block and gap junction 75 
inhibition. 76 
 77 
Abbreviations: AP, action potential; CV, conduction velocity; dF/dt, rate of change in 78 
fluorescence.  79 
 80 
Keywords: optical mapping; conduction velocity; action potential upstroke; anisotropic 81 
conduction 82 
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Introduction 107 
Cardiac optical mapping, using potentiometric dyes and fluorescent-light-sensitive digital 108 
cameras, allows researchers to study the electrophysiological properties of the heart at 109 
unparalleled spatial resolution. In intact heart tissue, the morphology of action potentials (APs) 110 
recorded with optical mapping typically exhibit reduced upstroke velocity and longer rise times 111 
compared to those recorded from the same tissues with microelectrode techniques[1; 2; 3; 4; 112 
5] (though not all studies agree).[6] Meanwhile, in isolated cardiac myocytes, rates of change 113 
for optical AP upstrokes have been reported to be similar to those recorded through 114 
microelectrodes.[7] The slower optical AP upstroke in intact cardiac tissue is thought to reflect 115 
the photon scattering effects of the tissue,[2; 8] as well as the rate of conduction of electrical 116 
waves within the myocardium.[1; 2; 3; 4; 5] Optical signals are integrated from a volume of 117 
tissue in which there is asynchronous activation and where spatial averaging of signals across 118 
and through the tissue is thought to slur the AP upstroke.[1; 2; 3; 4; 5] Indeed, computational 119 
modelling studies suggest that the rise time of optical AP in simulated human ventricle is a 120 
non-linear function of tissue conduction velocity (CV); where slower CV equates to an increase 121 
in the time for tissue activation and therefore a slower AP upstroke.[3] There has, however, 122 
been no experimental examination of the impact of conduction slowing on optical AP upstroke 123 
morphology in intact hearts.  124 
Slowing of CV can occur through multiple mechanisms, including acute ischaemia, tissue 125 
remodelling (hypertrophy and fibrosis), reduced sodium channel availability, and reduced gap 126 
junction coupling. Sodium channel block reduces the number of available sodium channels and 127 
decreases the transmembrane sodium current, which slows tissue CV. It is well established that 128 
concurrently with slowing CV, sodium channel block reduces the rate of maximum AP 129 
depolarisation (dV/dtmax) [9; 10; 11]. Meanwhile, gap junction inhibition slows tissue CV due 130 
to the reduction in current (source) flowing into neighbouring myocytes (sink) [12]. Model 131 
studies suggest that gap junction uncoupling slows CV, yet results in increased rate of AP 132 
depolarisation contrasting with observations in the presence of sodium channel blockers [13; 133 
14]. These predictions however are inconsistently supported [15; 16; 17] or disputed [12; 18; 134 
19; 20; 21] by experimental data using a variety of experimental models, techniques and gap 135 
junction uncoupling interventions.  136 
 137 
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In principle, the rate of change of an optical AP upstroke is a function of 1) the intrinsic AP 138 
upstroke within each individual myocyte, 2) the activation delay across and through the tissue 139 
integrated by each camera pixel, and 3) the photon scattering effects of the tissue (which 140 
increases the volume of tissue that contributes to the signal).[8] Whether any differential effects 141 
of ischemia, sodium channel block and gap junction inhibition would be evident in optically 142 
recorded APs is not known. The present study sought to determine the relationship between 143 
tissue CV and optical AP upstroke velocity at different fractional AP levels during acute 144 
ischaemia, sodium channel block and gap junction inhibition.  145 
 146 
 147 
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 165 
Materials and methods 166 
Animal welfare 167 
All procedures were undertaken in accordance with ethical guidelines set out by the UK 168 
Animals (Scientific Procedures) Act 1986 and Directive 2010/63/EU of the European 169 
Parliament on the protection of animals used for scientific purposes. Studies conformed to the 170 
Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes 171 
of Health under assurance number A5634-01. Studies were approved by the University of 172 
Birmingham Welfare and Ethical Review Board. 173 
 174 
Optical mapping 175 
Mouse hearts 176 
Male mouse (C57/BL6, 25-30g, Charles River, UK) hearts were isolated under isoflurane 177 
induced anaesthesia (4% in 100% O2) with concomitant intraperitoneal injection of heparin 178 
(100 units injected 5-minutes before heart isolation). Hearts were retrogradely perfused via the 179 
aorta at a perfusion pressure of 70-80mmHg with an oxygenated crystalloid buffer, containing 180 
(in mM); NaCl 114, KCl 4, CaCl 1.4, NaHCO3 24, NaH2PO4 1.1, glucose 11.0 and sodium 181 
pyruvate 1.0 (pH 7.4, 37oC). Blebbistatin was added to the perfusate at a concentration of 182 
15mol/L and solutions were continuously passed through a nitrocellulose filter (5m pore 183 
diameter). Once contraction had abated, the potentiometric dye Rh-237 was loaded by injection 184 
into the perfusion line. 100mL of stock solution (1.25mg/mL in DMSO) was injected over a 185 
period of 5-minutes. Final DMSO concentration was 0.001%. Hearts were illuminated at 186 
53025nm and emitted light >630nm was collected via an Olympus MVX10 stereomicroscope 187 
and Evolve Delta 512x512 EMCCD camera. Images were taken from the anterior left and right 188 
ventricular surface. Unless stated, data was collected at an acquisition sampling rate of 1kHz 189 
with a pixel width of 156m.  190 
 191 
During recordings hearts were paced with 1ms pulses with a 110ms cycle length from the 192 
epicardial surface at 4x the diastolic threshold using a bipolar pacing electrode (electrode 193 
spacing ~1mm). Recording time was 5-secounds. Hearts were subjected to interventions to 194 
alter ventricular CV. Namely, these were (i) 3-minutes of low-flow global ischaemia (25% of 195 
original flow rate) (ii) increasing concentrations of the sodium channel blocker flecainide (1-196 
3mol/L, total perfusion time 30-45minutes) (iii) increasing concentrations of the gap junction 197 
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inhibitor carbenoxolone (10-50mol/L, total perfusion time 30-45minutes). The pacing 198 
threshold was selected to ensure electrical capture during low-flow ischaemia protocols.  199 
 200 
Data processing  201 
Data processing was performed using an updated version of our freely available 202 
electrophysiological mapping software, ElectroMap   203 
(https://github.com/CXO531/ElectroMap)[22], which is based in MatLab (The MathWorks). 204 
To improve the signal-to-noise of optical APs, 40-sequential beats were aligned and averaged.  205 
A region of interest encompassing the ventricles (left anterior and right) was selected and data 206 
were processed, unless otherwise stated, using a Gaussian spatial filter (5x5 pixel area, standard 207 
deviation (σ)=1). No temporal filtering was applied.  208 
 209 
AP amplitude was normalised between 0 and 1. Normalisation is required because signal 210 
amplitude (and so differential fluorescent amplitude (dF/dt)) is affected by heterogeneities in 211 
dye loading and tissue illumination; which is a general limitation of single-wavelength 212 
fluorescent indicators. To quantify the AP upstroke morphology, we computed the maximum 213 
differential value of the optical AP upstroke (dF/dtmax). As described in previous studies, the 214 
fractional level that dF/dtmax occurs at was defined as VF* [23]. In some studies, we also 215 
measured dF/dt at different fractional levels between 0.1 and 0.9 (dF/dt0.1 - dF/dt0.9). Unless 216 
stated otherwise, cubic spline interpolation was applied to increase the effective sampling rate 217 
from 1 to 16kHz. Local tissue activation times were measured as the time of the maximum 218 
upstroke velocity (i.e. time of dF/dtmax and VF*)[24]. CV was calculated from the isochronal 219 
maps using the polynomial multi vector method with a 5x5 pixel area[22; 25].   220 
 221 
Analysis and statistics  222 
Hearts with signs of thrombi or with an initial heart rate less than 250 beats per minute were 223 
terminated and excluded. Hearts were randomised to different treatments prior to the 224 
experiments, but the nature of the paired (within heart) experimental design meant that blinding 225 
was unfeasible. However, excluding the initial determination of the region of interest, data 226 
were processed automatically with the same analytical steps and without user input, thus 227 
limiting sources of bias and error. Data analysis and statistical analysis was performed in 228 
GraphPad Prism (v8, GraphPad Software, USA).  In all data presented, the mean value of dF/dt, 229 
CV or VF
* from the entire analysed field of view was calculated for each individual heart. The 230 
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mean data (n=1 for each heart) was then used for statistical tests, i.e. n=14 hearts for ischemia-231 
reperfusion, n=7 for flecainide/carbenoxolone treatment respectively. Comparisons were 232 
paired (within experiment) and thus analysis was performed using paired t-tests, or repeated 233 
measures one- or two-way ANOVA with Bonferonni post-hoc tests. Statistical significance 234 
was taken as p<0.05. Unless otherwise stated, data is presented as Tukey’s boxplots.  235 
 236 
Results 237 
Relationship between optical AP upstroke velocity, conduction velocity and VF* 238 
VF* is the fractional amplitude at which the optical AP upstroke has its fastest rate of rise and 239 
is shown in previous studies to reflect the subsurface orientation of depolarising wavefronts as 240 
they spread through the myocardium.[3; 26; 27; 28] Here we examine the relationship between 241 
VF*, the maximum rate of change of the optical AP (dF/dtmax) and pattern electrical propagation 242 
in the intact heart. Figure 1 shows data from a representative mouse ventricle during epicardial 243 
pacing (point stimulation). Pacing was associated with an anisotropic pattern of conduction 244 
with fast (longitudinal) and slow (transverse) conduction paths. A typical oval isochronal map 245 
is shown in Figure 1a, where the faster conduction is indicated by the red arrow and the slowest 246 
conduction path by the black arrow. To the right is the corresponding VF* map in the same 247 
heart (Figure 1b). Consistent with previous reports, VF
*
 was low (0.5 or less) along the 248 
longitudinal axis, and high (greater than 0.5) in the transverse direction.[3; 26; 27; 28]  249 
 250 
Figure 1c shows the corresponding maximum rate of change of fluorescence (dF/dtmax) map. 251 
dF/dtmax was measured as the maximum of the first derivative of the normalised optical AP 252 
trace (signal amplitude normalised from 0 to 1). Faster rates of changes are observed to align 253 
along the faster, longitudinal, conduction path. Differences in the morphology of APs in 254 
longitudinal and transverse conduction paths are shown in the example traces in Figure 1d. In 255 
keeping with previous reports, the foot of the action potential was shallow along the transverse 256 
conduction path, where VF* is high, and steep along the longitudinal conduction path, where 257 
VF* is low [26]. The corresponding dF/dt traces derived from these example action potentials 258 
are shown to the right. Along the faster, longitudinal, path (region 1), a larger maximum dF/dt 259 
value is present. Figure 1e shows the pixel to pixel correlation of local CV with dF/dtmax before 260 
and after treatment with 2µM flecainide in this representative mouse heart (see below for 261 
further results on the effect of flecainide). A positive linear correlation is observed, with faster 262 
local CV areas exhibiting larger dF/dtmax. 263 
 264 
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 265 
 266 
Impact of conduction slowing on optical AP upstroke velocity 267 
The experiments described below were designed to quantify the effects of interventions that 268 
cause conduction slowing on the maximum rate of change of the optical AP upstroke (dF/dtmax) 269 
and at different fractional AP amplitudes (dF/dt0.1 - dF/dt0.9). 270 
 271 
Low-flow ischaemia 272 
Data presented in Figure 2 summarise the effects of a short period of low-flow global ischaemia 273 
(25% of the initial flow-rate) and subsequent flow-restoration (reperfusion) on ventricular 274 
conduction in the perfused mouse heart. Reduced coronary perfusion results in the build-up of 275 
metabolic by-products, acidification of the cell, and the accumulation of potassium ions in the 276 
extracellular space; all of which drive increase in the resting membrane potential, reduce 277 
sodium channel availability and slow CV[29; 30]. Representative activation maps during 278 
control conditions, during ischemia and following reperfusion are shown in figure 2a. In the 279 
mouse heart, a short (3-minute) period of low-flow ischaemia was associated with a progressive 280 
slowing of ventricular CV as seen by a prolongation of activation time and the tightening of 281 
isochronal lines. Corresponding representative dF/dtmax maps are shown in Figure 2b. Slowing 282 
of CV was paralleled by a decrease in dF/dtmax, indicative of a slowing of optical AP upstroke 283 
velocity. Data summarising the temporal response in dF/dtmax from all areas of the heart are 284 
shown in Figure 2c (black). It is well established fractional value at which dF/dtmax occurs 285 
(VF
*), is dependent on the transmural wave orientation, with VF
* ~ 0.5 reflecting parallel 286 
conduction to the epicardial surface [3; 26; 27; 28]. We hence repeated the analysis but 287 
restricted measuring dF/dtmax to pixels in which 0.45 ≤  VF*  ≤ 0.55, Figure 2c (red). This did 288 
not significantly alter dF/dtmax response to ischemia-reperfusion.  289 
 290 
The corresponding changes in mean tissue CV are shown in Figure 2d. Figure 2e shows the 291 
change in AP upstroke velocity during low-flow ischaemia at each at different fractional AP 292 
levels ranging from 0.1 to 0.9. A decrease in dF/dt due to ischemia is seen at all fractional 293 
levels of the AP, not just dF/dtmax. On reperfusion, tissue CV and dF/dtmax gradually recovered 294 
to control values. In summary, ischaemia was associated with a predictable and reversible 295 
slowing of CV that was paralleled by a decrease in the maximum rate of change of the optical 296 
AP upstroke, and at different fractional levels of the upstroke. 297 
 298 
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Sodium channel block and gap junction inhibition 299 
The effects of reducing sodium channel and gap junction availability/conductance were 300 
examined using flecainide, a sodium channel blocker, and carbenoxolone, a gap junction 301 
inhibitor. Data are presented in Figure 3. Both flecainide and carbenoxolone were associated 302 
with a concentration-dependent slowing of ventricular CV and corresponding reduction in 303 
dF/dtmax. Typical AP recordings from a single pixel before and after drug perfusion are 304 
presented in Figure 3a and 3d for flecainide and carbenoxolone, respectively. Both drugs were 305 
associated with a decrease in amplitude-normalised dF/dt, as shown in the relative right-hand 306 
traces. Concentration-dependent slowing of dF/dtmax are shown in panels b&e of Figure 3. The 307 
corresponding change in CV is shown in panels c&f for flecainide and carbenoxolone, 308 
respectively.  309 
 310 
Dependence of optical AP upstroke velocity on tissue CV 311 
Figure 4a shows the relationship between tissue CV and maximum optical AP upstroke 312 
velocity, including data for low-flow ischaemia, flecainide and carbenoxolone protocols. 313 
Figures 4a show that in spite of their differing mechanisms of action, all data points fall on a 314 
simple linear relationship, with no obvious separation in the responses to ischaemia, flecainide 315 
and carbenoxolone. The same holds for dF/dt measured at the foot (dF/dt0.1, Figure 4b red) and 316 
head (dF/dt0.9, Figure 4b black) of the AP upstroke. A non-linear relationship between tissue 317 
CV and rise-time (defined as time between 10 and 90% amplitude of the depolarisation) of the 318 
optical AP was found, as shown in Figure 4c, where a non-linear exponential decay better 319 
matched the observed relationship.  320 
 321 
Influence of sampling rate and spatial resolution 322 
Figure 5a&b summarises the effects of altering sampling frequency and spatial resolution 323 
(pixel width) on optical AP morphology in isolated perfused mouse hearts. Data presented in 324 
Figure 5a show a strong dependence on sampling rate, with a direct correlation between 325 
increases in acquisition sampling frequency and increased maximum optical AP upstroke 326 
velocity. Figure 5b shows the impact of post-acquisition pixel-binning on AP upstroke velocity 327 
in recordings made at low and high-magnification, equating to initial pixel widths of 156µm 328 
and 20µm, respectively. Binning pixels (2x2, 3x3 …) led to a reduction in maximum optical 329 
AP upstroke velocity in recordings made with low-magnification (open circles), but not those 330 
recorded at higher-magnification (open squares) in the pixel width ranges tested. Figure 5c&d 331 
similarly summaries the results of altering acquisition sampling frequency and spatial 332 
In revi
ew
11 
 
resolution on the fractional level at which the optical AP exhibits dF/dtmax (VF
*). Figure 5c 333 
shows that sampling rate also effects VF
*, with increased sampling rates resulting in increased 334 
measured VF
*. Figure 5d shows that acquisition pixel width also alters measured VF
*, with 335 
lower magnification (larger pixel with of 156µm) increasing VF
*. Pixel binning however did 336 
not alter VF
*. 337 
 338 
We hypothesised that at smaller pixel sizes (higher-magnification), the intrinsic AP upstroke 339 
within a single myocyte would play a more prominent role in determining AP upstroke 340 
morphology. If gap junction coupling by carbenoxolone does indeed increase dV/dtmax, we 341 
would therefore expect at higher magnification a carbenoxolone induced increase in dF/dtmax.    342 
However, data presented in Figure 5e show this not to be the case, as carbenoxolone was 343 
associated with a concentration-dependent decrease in optical AP upstroke velocity when 344 
recording at high-magnification from the ventricular free wall (20m pixel width) (Figure 5e). 345 
This is opposite to observed effects of gap junction inhibition on AP upstroke in microelectrode 346 
recordings but is in keeping with data presented in Figure 3 for lower-magnification optical 347 
mapping recordings (156m pixel width).  348 
 349 
Influence of image and signal processing  350 
Figure 6a&b demonstrates the effects of spatial and temporal filtering on optical AP upstroke 351 
velocity. Figure 6a shows that application spatial filtering reduces dF/dtmax. However, at kernel 352 
sizes of 5x5 pixels and larger (for the gaussian spatial filter applied herein), spatial filtering 353 
kernel size does not impact on measured dF/dtmax. Temporal filtering reduces dF/dtmax in a 354 
frame size dependent manner. Figure 6c shows the effects of cubic spline interpolation at 355 
increasing effective sampling rates (from 1kHz acquisition sampling rate). dF/dtmax increases 356 
with interpolation, however interpolation to extreme high effective sampling rates (to 256kHz) 357 
does not substantially alter measured dF/dtmax values from ‘moderate’ interpolation up to 358 
16kHz.  359 
  360 
Discussion 361 
It has been recognised for some time that the heterogeneity of activation of the myocardium is 362 
an important determinant of the rate of change and rise time of optically-recorded APs.[1; 2; 363 
3; 4; 5] The present study is the first to compare the effects of interventions that slow cardiac 364 
conduction on the morphology of optical APs recorded from intact hearts. Our results show 365 
I  evi
e
12 
 
that optical AP upstroke velocity is sensitive to changes in local conduction due to low-flow 366 
ischaemia, sodium channel blockade and gap junction inhibition. For all study interventions, 367 
the change in maximum AP upstroke velocity was found to be directly proportional to the 368 
corresponding change in tissue CV. This finding suggests that divergent mechanism-dependent 369 
effects, shown in previous studies using microelectrode recording techniques. [9; 10; 11; 12; 370 
31], do not alter the effects of CV changes on the optical recorded AP upstroke.  371 
 372 
During ventricular pacing, we observed a clear anisotropic pattern in optical dF/dtmax maps, 373 
with more rapid AP upstroke velocities aligned along the direction of the most rapid rates of 374 
conduction (and vice versa). This observation differs from previous reports utilising 375 
microelectrode recording techniques, where it is established that the rate of change of the action 376 
potential upstroke is slowest along the fastest conduction path.[13; 14] The biophysical basis 377 
for this observation relates to differences in intracellular coupling along the longitudinal and 378 
transverse conduction paths. With greater coupling, as occurs in the longitudinal direction, 379 
more depolarising current flows into neighbouring cells (reduced source-sink ratio).[13; 14] 380 
The net effect is faster CV but slower cellular AP upstroke velocity. The opposite is true in the 381 
transverse direction. This phenomenon was clearly explained in seminal studies by Spach and 382 
colleagues.[13; 14] However, the results of our study demonstrate that such a relationship does 383 
not hold for optical mapping recordings, where it appears AP upstroke velocity is a linear 384 
function of local CV.  385 
 386 
It is already known that whilst optical AP upstroke velocities in single cells are comparable to 387 
those recorded with microelectrodes, in intact tissue the upstroke of the optical AP is 2-5x 388 
slower.[1; 32] Slowing of the optical AP upstroke is thought to arise from the summing of 389 
signals from a volume of tissue in which there are asynchronous activation times (see later 390 
discussion on photon scattering).[1; 2] In this paradigm, slower CV, leading to greater 391 
asynchrony in activation, would lead to a slower AP upstroke, in keeping with our experimental 392 
observations. Several findings from the present study support this interpretation. For instance, 393 
despite their differing mechanisms of action, CV and dF/dtmax values for ischaemia, flecainide 394 
and carbenoxolone protocols all fall on a simple linear relationship. It has been suggested that 395 
gap junction inhibition slows CV in conjunction with a preserved or increased AP upstroke 396 
velocity, when recorded by microelectrode techniques. This has been reported in several 397 
studies and follows logically from the work of Spach and colleagues [13; 14; 15; 16; 31].There 398 
are however several independent studies suggesting otherwise [18; 19; 20; 21] . In the present 399 
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study, faster CV was associated with more rapid upstroke velocities in all interventions, 400 
strongly implying that local tissue CV, and not tissue excitability (i.e. the intrinsic upstroke 401 
velocity of single myocytes), is the major determinant of the upstroke velocity of optically 402 
recorded APs. Similar finding was found by Entz et al in optically mapped intact guinea pig 403 
myocardium, with slowed CV induced by carbenoxolone resulting in prolonged optical rise 404 
times [18]. Furthermore, this conclusion is indirectly supported by the findings of Hyatt et al., 405 
who found no correlation between microelectrode and optical AP upstroke velocities measured 406 
in the “same” region of isolated porcine right ventricle preparations.[26] Our experimental 407 
results also corroborate computational predictions of a non-linear relationship between the rise 408 
time of the optical AP and tissue CV.[3] 409 
 410 
Notably, we found that the above experimental observations remained true even when 411 
recording data at higher-magnifications, with pixel widths as small as 20m, wherein 412 
carbenoxolone caused a comparable slowing of optical AP upstroke velocity as that observed 413 
in lower-magnification recordings. This is an interesting observation, as we originally 414 
hypothesised that the local AP upstroke (i.e. that of the individual myocytes) would become 415 
more dominant with smaller pixel widths, but we found this not to be the case.  A likely 416 
explanation for this finding is the contribution of signals from within the ventricular wall, as 417 
well as the distortion of optical signals caused by fluorescent photon scattering within the 418 
tissue.[8]  Illumination light, which excites membrane bound potentiometric dyes, penetrates 419 
in to cardiac tissue and emitted fluorescent photons arising several hundred microns into the 420 
tissue contribute to the optical AP signal. Thus, the reduction in optical AP upstroke velocity 421 
with carbenoxolone, even when recording at high-magnification, may simply reflect the spatial 422 
differences in activation through the ventricular wall. Moreover, fluorescent photons undergo 423 
scattering events as they traverse to the tissue boundary, and due to these scattering events the 424 
photons detected on a single camera pixel originate from a widely distributed 3D tissue 425 
volume.[8] Computational models suggest that only a small proportion of the optical AP signal 426 
originates in tissues that are located geometrically beneath the recording pixel. Scattered 427 
photons contain information on the transmembrane potential at their site of origin, and so the 428 
recorded signal is the weighted average of the transmembrane potential levels within the 429 
scattered volume of tissue.[8] Our experimental data suggest that photon scattering effects 430 
dominate any local changes in AP upstroke in optical signals recorded from the mouse 431 
ventricle, even at high-magnification, and that this underpins the strong linear correlation 432 
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between AP upstroke velocity and tissue CV. However, it is important again here to note the 433 
conflicting reports on the effects of gap junction uncoupling on the cellular AP upstroke, which 434 
may also explain our high-magnification findings [18; 19; 20; 21]. The mechanisms of camera 435 
tissue integration and photon scattering also explains why maximum dF/dt was correlated with 436 
regions of fastest CV, which diverges from the negative correlation observed for 437 
microelectrode recorded APs.[13; 14] 438 
 439 
Ding et al. have previously reported on the use of maximum dF/dt of the optical AP upstroke 440 
for quantification of differences in depolarisation between normal and infarct border-zone in 441 
the heart of rats post myocardial infarction.[33] Here the authors analysed AP upstroke without 442 
controlling for differences in optical AP amplitude, which has its limitations. Optical AP 443 
amplitude depends not only on the absolute AP amplitude in cells under the recording site, but 444 
also heterogeneities in dye loading, regional illumination, and active tissue volume. Thus, it is 445 
unclear whether the reported differences in the study of Ding et al. reflect differences in local 446 
“excitability” or simply differences in dye loading / viable tissue within the border zone. On 447 
the contrary, amplitude-normalised signals may underestimate the magnitude of conduction 448 
slowing, in scenarios where a real change in AP amplitude plays a causal role in the slowing 449 
of CV (e.g. acute myocardial ischaemia). Several studies have also reported on the related 450 
measure of AP rise time,[34; 35] though not in the context of quantifying electrical conduction 451 
in the heart, but rather as a comparison of AP kinetics with traditional microelectrode 452 
recordings. Computational modelling studies have predicted that optical AP rise time is a non-453 
linear function of CV, which was confirmed in the present experiments.[3] In studies of 454 
anisotropic conduction, Fast and Kléber reported no difference in dV/dt (more accurately 455 
rescaled dF/dt) in optical AP recordings associated with longitudinal (slower) and transverse 456 
(faster) conduction in cultured neonatal myocyte monolayers.[36] This differs from the present 457 
studies observation of a correlation between anisotropic conduction patterns and dF/dt. The 458 
divergence in our results is not easily explained but may simply reflect the experimental model 459 
used (monolayers vs. intact hearts).  460 
 461 
There has been substantive work on the contribution of subsurface signals to the morphology 462 
of the optical AP recorded in intact tissues. It is known that the fractional amplitude at which 463 
the optical AP upstroke has its maximal derivative (VF*) is a function of the subsurface 464 
orientation of electrical wavefronts in the heart.[3; 26; 27; 28] During epicardial pacing, this 465 
largely reflects the rotation of fibres in the ventricle, which is a major determinant of 466 
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anisotropic conduction.[37] The results of the present study confirm these observations in the 467 
mouse heart, reproducing the typical VF* patterns expected for epicardial point stimulation.[26; 468 
28].  469 
 470 
Study limitations 471 
We show that AP upstroke velocity is dependent on the temporal sampling rate and spatial 472 
resolution, and for the same reason will be affected by signal processing techniques like spatial 473 
and temporal filtering and ensemble averaging. For example, we found that temporal filtering 474 
with a 3rd order Savitizy-Goaly filter reduced baseline dF/dtmax values in a frame size dependent 475 
manner, and hence was not utilised. Thus, absolute AP upstroke is dependent on the 476 
experimental settings and data processing steps used. These considerations extend to use of 477 
interpolation to increase the effective sampling rate. Interpolation was applied in this study as 478 
the short timescale of the AP upstroke means dF/dtmax and VF* is likely to occur between 479 
sampling points at 1kHz sampling frequency (1ms framerate). 16kHz spline interpolation was 480 
applied as it was observed that lower effective framerate reduced measured dF/dtmax values, 481 
while higher order interpolation (up to 256kHz) did not change dF/dtmax. However, the Nyquist 482 
theorem suggests that 1kHz sampling rate is only sufficient to accurately resolve signal 483 
frequency content less that 500Hz, meaning interpolation to 16kHz may be inaccurate. 484 
Furthermore, only one interpolation method (cubic spline) was tested. Hence, further 485 
investigation is required, potentially utilising ‘ground truth’ computer models of optical APs 486 
in intact tissue, to optimise data processing for measurement of maximum and fractional dF/dt.  487 
 488 
The present studies were performed in isolated mouse hearts, and additional studies are 489 
required to establish the properties of the optical AP upstroke in other species. It seems highly 490 
probable that our findings in the mouse ventricle will be more broadly applicable, though the 491 
absolute relationship between optical AP upstroke dF/dtmax and tissue CV will be species- and 492 
setup- dependent.  493 
 494 
Conclusion 495 
In intact mouse hearts, slowing of optical AP upstroke velocity is directly proportional to the 496 
change in CV associated with low-flow ischaemia, sodium channel block and gap junction 497 
inhibition. 498 
 499 
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Figure 1. Mapping of electrical propagation in the intact heart. Representative maps from a single experiment showing different measures of 
electrical propagation in the intact mouse heart. a) Isochronal map illustrating local tissue activation times during pacing from the central region. 
A pattern of anisotropic conduction can be seen, as indicated by the red and black arrows. b) A similar anisotropic pattern is observed in the 
corresponding VF* map, a measure of the pattern of subsurface wavefront orientation. c) dF/dtmax of the optical AP upstroke (signal amplitude 
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normalised between 0 and 1). d) Examples of optical AP upstroke morphology from region [1] and region [2]. The corresponding derivatives are 
shown to the right. e) Pixel by pixel correlation between   dF/dtmax and CV before (control) and after treatment with 2µM flecainide.  
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Figure 2. Changes in optical AP upstroke morphology during low-flow ischaemia. a) 
Representative activation maps in control conditions, during ischaemia and with tissue 
reperfusion. b) Representative optical AP upstroke velocity maps in control conditions, during 
ischaemia and with tissue reperfusion. Missing pixels due to location of pacing electrode.  c) 
Data from 14 hearts showing whole tissue mean changes in upstroke dF/dtmax at different 
fractional AP amplitudes during the ischaemia-reperfusion protocol. Black shows data when 
dF/dtmax was calculated from all pixels, while red shows data when analysis was restricted to 
pixels with VF
* between 0.45 and 0.55 to focus on areas with conduction parallel to the 
epicardial surface. d) Corresponding changes in whole tissue mean CV. One-way ANOVA 
with Bonferonni correction. Time point vs. Control (time = 0s); *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001. e) Comparison of dF/dt at different fractional amplitudes in 
control conditions (time = 0s) and during ischaemia (time point 180s). Two-way ANOVA with 
Bonferroni multiple comparison testing for each fractional amplitude dF/dt. Ischaemia vs. 
Control; *p<0.05, **p<0.01, ***p<0.001,****p<0.0001 
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Figure 3. Changes in optical AP upstroke morphology with flecainide and carbenoxolone. 
a) Representative AP upstroke morphologies and corresponding dF/dt for recordings in control 
conditions and with 3M flecainide. b) Data from 7 hearts showing changes in upstroke 
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dF/dtmax with increasing concentrations of flecainide. c) Corresponding changes in tissue CV. 
One-way ANOVA with Bonferonni post-hoc tests. Flecainide vs. Control (0M); ***p<0.001, 
****p<0.0001. d) Representative AP upstroke morphologies and corresponding dF/dt for 
recordings in control conditions and with 50µM carbenoxolone. e) Data from 7 hearts showing 
changes in upstroke dF/dtmax with increasing concentrations of carbenoxolone. f) 
Corresponding changes in tissue CV. One-way ANOVA with Bonferonni post-hoc tests. 
Carbenoxolone vs. Control (0µM); ***p<0.001, ****p<0.0001.  
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Figure 4. Correlations of optical AP upstroke velocity, rise time and CV. a) Correlation 
between CV and dF/dtmax of the optical AP upstroke. b) Correlation between CV and dF/dt0.9 
(black) and dF/dt0.1 (red) and of the optical AP upstroke. c) Corresponding correlation between 
CV and optical AP rise times (measured between 0.1 and 0.9 fractional levels of AP upstroke). 
Linear fit, a. Exponential, b. Data are mean ± SEM. Flecainide n =7 hearts. Carbenoxolone n=7 
hearts. Ischaemia-reperfusion n=14 hearts. 
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Figure 5. Effects of sampling frequency, magnification and pixel binning. a) Effects of 
altering acquisition sampling frequency on maximum optical action potential (AP) upstroke 
velocity b) Effects of pixel-binning on AP upstroke velocity at low- and high-magnification 
(initial pixel widths of 156m and 20m pixel width, respectively). c) Effects of altering 
acquisition sampling frequency on VF*. d) Effects of pixel-binning on AP upstroke velocity at 
low- and high-magnification on VF*. e) Responses to carbenoxolone at high-magnification 
(20m pixel width). Data from 4 hearts with representative AP and dF/dt traces for control 
conditions and following carbenoxolone treatment (50M). Note: Other than post processing 
binning (b and d), all data presented here was processed with spatial filtering and interpolation 
(to 16kHz) as set out in the methods. One-way ANOVA with Bonferonni post-hoc tests. 
**p<0.01, ****p<0.0001
0 100 200 300 400 500
0.0
0.1
0.2
0.3
0.4
Pixel width (m)
d
F
/d
t m
a
x
(u
n
it
s
/m
s
)
High-magnification
Low-magnification
**
****
Pixel width = 20m (n=4) [1kHz]
0 20 40 60
0.1
0.2
0.3
0.4
Carbenoxolone
concentration (mol/L)
d
F
/d
t m
a
x
(u
n
it
s
/m
s
)
e)
0.0 0.5 1.0
0.20
0.25
0.30
0.35
0.40
Sampling frequency (kHz)
d
F
/d
t m
a
x
(u
n
it
s
/m
s
)
(n=4)
a)
Control CBX (50M)
AP dF/dt
b)
(n=4)
0.0 0.5 1.0
0.50
0.52
0.54
0.56
0.58
0.60
Sampling frequency (kHz)
V
f*
0 100 200 300 400 500
0.0
0.2
0.4
0.6
0.8
Pixel width (m)
V
f*
High-magnification
Low-magnification
c) d)
In revi
ew
27 
 
Figure 6. Effects of data processing on maximum optical upstroke velocity (dF/dtmax). a) 
Effect of gaussian spatial filter pixel size. b) Effect of changing length/frame size of 3rd order 
temporal Savitzky-Golay (SG) filter. c) Effect of cubic spline interpolation to higher effective 
signal framerates. n=14 hearts. 
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